A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia
- PMID: 1636132
A comparison of outcome after resection for squamous cell carcinomas and adenocarcinomas of the esophagus and cardia
Abstract
Among 625 patients with squamous cell carcinoma and 134 patients with adenocarcinoma of the esophagus and cardia, a one stage resection was performed upon 375 patients of the squamous carcinoma group (excluding pharyngolaryngoesophagectomy) and 92 patients in the adenocarcinoma group. The patients formed the basis of the current analysis. Male to female ratio was 7:1 for those with squamous carcinoma compared with 3.6:1.0 for those with adenocarcinoma (p = 0.037). Most squamous carcinomas were located in the middle one-third (56.3 percent) and lower one-third (33.0 percent) of the esophagus. Adenocarcinomas were predominantly found at the cardia (91.3 percent) and lower one-third (6.5 percent). Postoperatively, respiratory complications occurred in 34.4 percent of patients in the group with squamous carcinoma and in 19.6 percent of patients in the group with adenocarcinoma (p = 0.01). Cardiac complications occurred in 28.3 percent of patients in the group with squamous carcinoma and in 16.3 percent of patients in the group with adenocarcinoma (p = 0.03). Anastomotic leaks were uncommon for both groups (4.3 and 5.4 percent, respectively). Anastomotic recurrence occurred in 6.1 and 7.6 percent of patients, respectively. Respiratory complications, malignant cachexia and sepsis accounted for most of the deaths in the hospital. The 30 day mortality rates for patients with squamous carcinoma and adenocarcinoma were comparable (4.8 and 6.5 percent, respectively) (p = 0.33). After 30 days, mortality rates differed significantly (11.7 and 3.3 percent, respectively) (p = 0.026). The overall hospital mortality rates, however, were comparable (16.5 and 9.8 percent, respectively) (p = 0.14). The overall five year survival rate for both groups was 15 percent. For patients with squamous carcinomas, the five year survival rate after curative resection was 31 percent compared with 5 percent for palliative resection. For patients with adenocarcinomas, the respective five year survival rates were 35 and zero percent. It was concluded that the two types of tumor differ significantly in the incidence of postoperative morbidity, but mortality and the long term survival rates were similar.
Similar articles
-
Adenocarcinoma of the esophagus and cardia.J Thorac Cardiovasc Surg. 1987 Jul;94(1):64-8. J Thorac Cardiovasc Surg. 1987. PMID: 3600009
-
[Transhiatal esophagectomy for carcinoma of the esophagus--our ten years experience].Zentralbl Chir. 2002 Nov;127(11):956-9. doi: 10.1055/s-2002-35829. Zentralbl Chir. 2002. PMID: 12476368 German.
-
Carcinoma of the hypopharynx, esophagus and cardia.Surg Gynecol Obstet. 1986 Mar;162(3):243-7. Surg Gynecol Obstet. 1986. PMID: 2420018
-
Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma.Ann Thorac Surg. 2004 Oct;78(4):1177-83. doi: 10.1016/j.athoracsur.2004.02.068. Ann Thorac Surg. 2004. PMID: 15464466 Review.
-
Standard resection for cancer of the esophagus and cardia.Surg Oncol Clin N Am. 1999 Apr;8(2):279-94. Surg Oncol Clin N Am. 1999. PMID: 10339646 Review.
Cited by
-
Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.Am J Pathol. 2010 Feb;176(2):939-51. doi: 10.2353/ajpath.2010.090118. Epub 2010 Jan 7. Am J Pathol. 2010. PMID: 20056838 Free PMC article.
-
Diagnosis and treatment of esophageal neoplasms.Jpn J Cancer Res. 1995 Nov;86(11):993-1009. doi: 10.1111/j.1349-7006.1995.tb03012.x. Jpn J Cancer Res. 1995. PMID: 8567405 Free PMC article. Review.
-
Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem.Abdom Imaging. 1995 Jul-Aug;20(4):291-8. doi: 10.1007/BF00203356. Abdom Imaging. 1995. PMID: 7549728 Review. No abstract available.
-
microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin.J Biol Chem. 2011 Mar 25;286(12):10725-34. doi: 10.1074/jbc.M110.165654. Epub 2010 Dec 9. J Biol Chem. 2011. PMID: 21148309 Free PMC article.
-
Validity of studies suggesting preoperative chemotherapy for resectable thoracic esophageal cancer: A critical appraisal of randomized trials.World J Gastrointest Oncol. 2020 Jan 15;12(1):113-123. doi: 10.4251/wjgo.v12.i1.113. World J Gastrointest Oncol. 2020. PMID: 31966919 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical